Mark C. Willingham
Impact in
- Oncology top 0.05%
- Drug Transport and Resistance Mechanisms
- Cell Biology top 0.05%
- Cellular transport and secretion
Papers in
-
- Lipid Membrane Structure and Behavior 36
- Glycosylation and Glycoproteins Research 25
- Immunology 84
- Toxin Mechanisms and Immunotoxins 66
- Co-authors
- Ira Pastan (162 shared papers)Michael M. Gottesman (19 shared papers)I Pastan (9 shared papers)Frederick R. Maxfield (10 shared papers)F Thiébaut (3 shared papers)Hironobu Hamada (2 shared papers)T Tsuruo (1 shared paper)Sheue-yann Cheng (40 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (36 papers)Journal of Histochemistry & Cytochemistry (32 papers)Journal of Biological Chemistry (25 papers)Cell (15 papers)Experimental Cell Research (14 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Mark C. Willingham
434 papers receiving 33.1k citations
Mark C. Willingham's Hit Papers
Peers
Comparison fields: 5 of 165
- Oncology 9.2k
- Cell Biology 5.1k
- Immunology 5.5k
- Molecular Biology 17.9k
- Biotechnology 2.1k
Countries citing papers authored by Mark C. Willingham
This map shows the geographic impact of Mark C. Willingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Willingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Willingham more than expected).
Fields of papers citing papers by Mark C. Willingham
This network shows the impact of papers produced by Mark C. Willingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Willingham. The network helps show where Mark C. Willingham may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark C. Willingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 436 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Hit paper breakdown → | 1987 | 2451 |
| 2 | The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Hit paper breakdown → | 1982 | 1312 |
| 3 | Expression of Multidrug Resistance Gene in Human Cancers Hit paper breakdown → | 1989 | 1139 |
| 4 | Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. Hit paper breakdown → | 1980 | 765 |
| 5 | Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells Hit paper breakdown → | 1978 | 602 |
| 6 | Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. Hit paper breakdown → | 1989 | 546 |
| 7 | Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones Hit paper breakdown → | 1980 | 505 |
| 8 | Journey to the Center of the Cell: Role of the Receptosome Hit paper breakdown → | 1981 | 469 |
| 9 | 1985 | 446 | |
| 10 | 1988 | 444 | |
| 11 | 1979 | 414 | |
| 12 | 1987 | 413 | |
| 13 | 1997 | 405 | |
| 14 | 2010 | 384 | |
| 15 | 1980 | 368 | |
| 16 | 1980 | 366 | |
| 17 | 1978 | 350 | |
| 18 | 1990 | 335 | |
| 19 | 2007 | 332 | |
| 20 | 2010 | 326 |
About Mark C. Willingham
Mark C. Willingham is a scholar working on Molecular Biology, Immunology, Cell Biology, Oncology and Biotechnology, having authored 436 papers that have together received 35.6k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (66 papers), Cellular transport and secretion (50 papers), Monoclonal and Polyclonal Antibodies Research (48 papers), Transgenic Plants and Applications (42 papers), Lipid Membrane Structure and Behavior (36 papers), Virus-based gene therapy research (29 papers), Glycosylation and Glycoproteins Research (25 papers) and Drug Transport and Resistance Mechanisms (25 papers). The work is most often cited by research in Oncology (9.2k citations), Cell Biology (5.1k citations), Immunology (5.5k citations), Molecular Biology (17.9k citations) and Biotechnology (2.1k citations). Mark C. Willingham has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Ira Pastan, Michael M. Gottesman, I Pastan, Frederick R. Maxfield, F Thiébaut, Hironobu Hamada, T Tsuruo, Sheue-yann Cheng, Glenn Merlino and John A. Hanover. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Histochemistry & Cytochemistry, Journal of Biological Chemistry, Cell and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.